X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Congratulations to our 2022 Working for Cures Employee Champions

By Stephen J. Ubl  |    November 10, 2022
The Working for Cures Employee Champion Awards celebrate the real people in our industry who go above and beyond to advance science and support the work our industry does for patients.   Read More

Protecting against influenza: A conversation with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus

By Mike Ybarra  |    October 13, 2022
Our industry is at the forefront of fighting the annual influenza virus. I recently had the chance to connect with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus about...   Read More

An open letter to Congress: Stand with patients and future cures

By Stephen J. Ubl  |    August 4, 2022
I recently joined PhRMA board members in penning the letter below to Congress, urging them to abandon their latest drug pricing proposal. You can read the letter here or below:   Read More

PhRMA member companies’ R&D investments reach record high of $102.3 billion in 2021

By Tim McClung  |    July 18, 2022
PhRMA member companies’ continued investment in research and development (R&D) has led to new medicines transforming human health. Innovative biopharmaceutical approaches to treating patients for a...   Read More

Biopharmaceutical researchers to discuss the value of R&D with Congress

By Stephen J. Ubl  |    June 9, 2022
Today, researchers from PhRMA member companies will meet virtually with members of Congress and Capitol Hill staff to discuss the importance of biopharmaceutical innovation in bringing new treatments...   Read More

A conversation with Barry Greene, CEO of Sage Therapeutics

By Stephen J. Ubl  |    May 4, 2022
Our industry continues working to build a more resilient, affordable and equitable health care system. As part of Mental Health Awareness Month, I recently had the opportunity to connect with PhRMA...   Read More

Stephanie Dyson of BMS on reducing health disparities

By Guest Contributor  |    April 27, 2022
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

Biopharmaceutical industry drives economic growth in all 50 states

By Tim McClung  |    March 14, 2022
The innovative biopharmaceutical industry has long been a significant driver of the nation’s economic growth and a key contributor to state and regional economies. A new report from TEConomy Partners...   Read More

Guest post: Joining forces to combat the COVID-19 mental health crisis

By Guest Contributor  |    February 17, 2022
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

Upcoming graduate student summit will showcase pathways to success within the biopharmaceutical industry

By Stephen J. Ubl  |    September 28, 2021
I am excited to join with Dr. Michael L. Lomax, President & CEO, UNCF; Dr. James Gillespie, President & Co-Founder, Center for Healthcare Innovation (CHI); and Dr. Chad Womack, Co-Founder and...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates